Invention Grant
- Patent Title: Heteroaryldiazepine derivatives as RSV inhibitors
-
Application No.: US15863216Application Date: 2018-01-05
-
Publication No.: US10398706B2Publication Date: 2019-09-03
- Inventor: Brian C. Shook , In Jong Kim , Jianming Yu , Thomas P. Blaisdell , Joseph Panarese , Yat Sun Or
- Applicant: Enanta Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore
- Main IPC: A61K31/551
- IPC: A61K31/551 ; C07D495/04 ; C07D471/04 ; C07D487/04 ; C07D491/04 ; C07D498/04 ; C07D513/04 ; A61P31/14
Abstract:
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof: These compounds are useful for treating Respiratory Syncytial Virus (RSV) infection. The present invention further relates to pharmaceutical compositions comprising these compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering to the subject a pharmaceutical composition comprising a compound of the invention.
Public/Granted literature
- US20180193352A1 HETEROARYLDIAZEPINE DERIVATIVES AS RSV INHIBITORS Public/Granted day:2018-07-12
Information query
